Insider Stock Trading History of Hambleton Julie


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Hambleton Julie since year 2005. The trader's CIK number is 1578771. At the time of this reporting, Hambleton Julie is the EVP & Chief Medical Officer of Five Prime Therapeutics Inc . (stock ticker symbol FPRX). See this page for all insider trading activities at Five Prime Therapeutics Inc .


Stock purchases, sales, and option exercises reported by insider Hambleton Julie since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2013-11-06 FPRX Five Prime Therapeutics Inc Buy 500 10.10 5,050
2013-09-18 FPRX Five Prime Therapeutics Inc Buy 800 14.75 11,800
2013-09-30 FPRX Five Prime Therapeutics Inc Buy 64 13.70 876
2014-08-22 FPRX Five Prime Therapeutics Inc Buy 400 10.75 4,300

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hambleton Julie (EVP & Chief Medical Officer of Five Prime Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.